IL-19 as a promising theranostic target to reprogram the glioblastoma immunosuppressive microenvironment
IL-19 is a promising theranostic target for reversing immunosuppression and restricting the invasive activity of chemoresistant GBM cells.
Authors
- Duen-Pang Kuo
- Cheng‐Yu Chen (ORCID: https://orcid.org/0000-0003-0428-4373)
- Justin Bo‐Kai Hsu
- Gilbert Aaron Lee (ORCID: https://orcid.org/0000-0003-1262-4702)
- Yung-Chieh Chen (ORCID: https://orcid.org/0000-0002-0333-428X)
- Yu-Wei Chang
- Yung‐Hsiao Chiang (ORCID: https://orcid.org/0000-0002-8426-4016)
- Ting-Wei Weng
- Chien‐Wei Wu (ORCID: https://orcid.org/0000-0001-7965-1997)
- Yi-Tien Li (ORCID: https://orcid.org/0000-0003-3834-2615)
- Liang-Wei Chen (ORCID: https://orcid.org/0000-0003-1907-7043)
- Wanli Lin (ORCID: https://orcid.org/0009-0001-9680-8973)
- Shiu‐Wen Huang
- Li‐Wen Tseng
- Hung‐Wen Kao (ORCID: https://orcid.org/0000-0002-7724-448X)
- Ying Chieh Wu
- Li-Chun Hsieh
- Cheng-Ying Chu
- Hsing-Jien Kung
- Sho-Jen Cheng
- Wan-Yuo Guo
Institutions
- Tri-Service General Hospital (TW)
- Taipei Medical University Hospital (TW)
- Taipei Veterans General Hospital (TW)
- Taipei Medical University (TW)
- National Defense Medical Center (TW)
- Yuan Ze University (TW)
Publication Details
- Journal
- Journal of Biomedical Science
- Published
- 2025-03-08
- DOI
- https://doi.org/10.1186/s12929-025-01126-w
- Citations
- 14
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 22.76
Funders
- Ministry of Science and Technology
- National Health Research Institutes